<?xml version="1.0" encoding="UTF-8"?><abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>http://api.elsevier.com/content/abstract/scopus_id/84895962809</prism:url><dc:identifier>SCOPUS_ID:84895962809</dc:identifier><eid>2-s2.0-84895962809</eid><prism:doi>10.1016/j.copbio.2014.02.010</prism:doi><dc:title>Application of TALEs, CRISPR/Cas and sRNAs as trans-acting regulators in prokaryotes</dc:title><prism:aggregationType>Journal</prism:aggregationType><srctype>j</srctype><citedby-count>1</citedby-count><prism:publicationName>Current Opinion in Biotechnology</prism:publicationName><dc:publisher>
Elsevier Ltd
</dc:publisher><source-id>15579</source-id><prism:issn>18790429</prism:issn><prism:volume>29</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:startingPage>46</prism:startingPage><prism:endingPage>54</prism:endingPage><prism:pageRange>46-54</prism:pageRange><prism:coverDate>2014-01-01</prism:coverDate><dc:creator><author auid="26323482400" seq="1"><ce:initials>M.F.</ce:initials><ce:indexed-name>Copeland M.F.</ce:indexed-name><ce:surname>Copeland</ce:surname><ce:given-name>Matthew F</ce:given-name><preferred-name>
<ce:initials>M.F.</ce:initials>
<ce:indexed-name>Copeland M.</ce:indexed-name>
<ce:surname>Copeland</ce:surname>
<ce:given-name>Matthew F.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/26323482400</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60032179" id="60032179"/></author></dc:creator><dc:description><abstract original="y" xml:lang="eng">
<ce:para>The last several years have witnessed an explosion in the understanding and use of novel, versatile trans-acting elements. TALEs, CRISPR/Cas, and sRNAs can be easily fashioned to bind any specific sequence of DNA (TALEs, CRISPR/Cas) or RNA (sRNAs) because of the simple rules governing their interactions with nucleic acids. This unique property enables these tools to repress the expression of genes at the transcriptional or post-transcriptional levels, respectively, without prior manipulation of cis-acting and/or chromosomal target DNA sequences. These tools are now being harnessed by synthetic biologists, particularly those in the eukaryotic community, for genome-wide regulation, editing, or epigenetic studies. Here we discuss the exciting opportunities for using TALEs, CRISPR/Cas, and sRNAs as synthetic trans-acting regulators in prokaryotes. Â© 2014 Elsevier Ltd.</ce:para>
</abstract></dc:description><link href="http://api.elsevier.com/content/abstract/scopus_id/84895962809" rel="self"/><link href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84895962809&amp;origin=inward" rel="scopus"/><link href="http://api.elsevier.com/content/search/scopus?query=refeid%282-s2.0-84895962809%29" rel="cited-by"/></coredata><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60032179" id="60032179"><affilname>University of Wisconsin Madison</affilname></affiliation><authors><author auid="26323482400" seq="1"><ce:initials>M.F.</ce:initials><ce:indexed-name>Copeland M.F.</ce:indexed-name><ce:surname>Copeland</ce:surname><ce:given-name>Matthew F</ce:given-name><preferred-name>
<ce:initials>M.F.</ce:initials>
<ce:indexed-name>Copeland M.</ce:indexed-name>
<ce:surname>Copeland</ce:surname>
<ce:given-name>Matthew F.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/26323482400</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60032179" id="60032179"/></author><author auid="55548395100" seq="2"><ce:initials>M.C.</ce:initials><ce:indexed-name>Politz M.C.</ce:indexed-name><ce:surname>Politz</ce:surname><ce:given-name>Mark C</ce:given-name><preferred-name>
<ce:initials>M.C.</ce:initials>
<ce:indexed-name>Politz M.</ce:indexed-name>
<ce:surname>Politz</ce:surname>
<ce:given-name>Mark C.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/55548395100</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60032179" id="60032179"/></author><author auid="10440817800" seq="3"><ce:initials>B.F.</ce:initials><ce:indexed-name>Pfleger B.F.</ce:indexed-name><ce:surname>Pfleger</ce:surname><ce:given-name>Brian F</ce:given-name><preferred-name>
<ce:initials>B.F.</ce:initials>
<ce:indexed-name>Pfleger B.</ce:indexed-name>
<ce:surname>Pfleger</ce:surname>
<ce:given-name>Brian F.</ce:given-name>
</preferred-name><author-url>http://api.elsevier.com/content/author/author_id/10440817800</author-url><affiliation href="http://api.elsevier.com/content/affiliation/affiliation_id/60032179" id="60032179"/></author></authors></abstracts-retrieval-response>
